Economic Impact of Dengue Illness
2011

Economic Impact of Dengue Illness in the Americas

publication Evidence: high

Author Information

Author(s): Donald S. Shepard, Laurent Coudeville, Yara A. Halasa, Betzana Zambrano, Gustavo H. Dayan

Primary Institution: Brandeis University

Hypothesis

What is the economic burden of dengue illness in the Americas?

Conclusion

Dengue illness in the Americas costs an estimated $2.1 billion per year on average, highlighting its substantial economic burden.

Supporting Evidence

  • Dengue illness in the Americas was estimated to cost $2.1 billion per year on average.
  • The burden for dengue exceeds that from other viral illnesses, such as HPV or rotavirus.
  • Ambulatory cases accounted for 72.9% of the total costs overall.
  • About 60% of dengue costs in the Americas correspond to indirect costs.
  • Brazil accounted for 40.9% of the total cost of dengue in the Americas.

Takeaway

Dengue is a really expensive sickness that costs a lot of money every year in the Americas, more than other similar diseases.

Methodology

The study synthesized existing data on dengue cases, costs, and underreporting to estimate the economic burden from a societal perspective.

Potential Biases

Some authors are affiliated with Sanofi Pasteur, which may introduce potential conflicts of interest.

Limitations

The study may underestimate the total economic consequences of dengue as it does not include costs related to vector control.

Digital Object Identifier (DOI)

10.4269/ajtmh.2011.10-0503

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication